General
Preferred name
NAPHAZOLINE HYDROCHLORIDE
Synonyms
NAPHAZOLINE HCL ()
Albalon ()
Rhinantin ()
Naphazoline (hydrochloride) ()
Naphthazoline (hydrochloride) ()
Vasocon ()
Naphazoline Nitrate ()
Antistin-Privine ()
Nafazair ()
Naphcon Forte ()
Gppe Nsl Soln ()
Opcon ()
NSC-35711 ()
Naphcon ()
Naphaz HCl ()
P&D ID
PD001845
CAS
550-99-2
35412-62-5
835-31-4
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Adrenergic (vasoconstrictor)
First approval
1971
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
EU-OPENSCREEN Bioactive Compound Library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
23
Properties
(calculated by RDKit )
Molecular Weight
246.09
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
2.81
TPSA
24.39
Fraction CSP3
0.21
Chiral centers
0.0
Largest ring
6.0
QED
0.87
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Neuroscience
GPCR/G protein
Apoptosis
Immunology/Inflammation
Neuronal Signaling
Protein Tyrosine Kinase/RTK
Target
Adrenergic Receptor
Interleukin Related
TNF Receptor
VEGFR
Source data